We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

GPhA Asks FDA To Create Task Force On Generic Biopharmaceuticals

News

Executive Summary

The agency should abandon its “arbitrator” role in the face of the brand industry’s continued reluctance to discuss a path forward, GPhA maintains. FDA should put together an analysis of the issues to be presented at an upcoming FDA/DIA meeting.